Publications by authors named "Zhain Mustufvi"
Article Synopsis
- The study aimed to explore the perspectives and potential preventive measures among individuals at risk of developing rheumatoid arthritis (RA) and to identify factors that influence their engagement in prevention activities.* -
- Nineteen participants, who were anti-CCP-positive with musculoskeletal symptoms but no synovitis, shared their experiences through semi-structured interviews, revealing themes of distress from symptoms, uncertainty about disease progression, and a willingness to adopt lifestyle changes to prevent RA.* -
- The analysis identified three participant types (proactive preventers, change considerers, and fearful avoiders) and highlighted that various factors, including symptom severity and personal knowledge, influence their approach to engaging in preventive behaviors.*
Objectives: Current evidence suggests that periodontal disease could be a causal risk factor for rheumatoid arthritis (RA) onset and progression. Earlier periodontal intervention in individuals at risk of RA could provide a unique opportunity to prevent or delay the onset of RA. This study aimed to explore the acceptability of periodontal treatment as a measure to potentially prevent RA among at-risk individuals and healthcare professionals.
View Article and Find Full Text PDFObjectives: The association of periodontal disease in people diagnosed with RA is emerging as an important driver of the RA autoimmune response. Screening for and treating periodontal disease might benefit people with RA. We performed a systematic literature review to investigate the effect of periodontal treatment on RA disease activity.
View Article and Find Full Text PDFThere is increasing evidence supporting an association between periodontal disease (PD) and rheumatoid arthritis (RA), both mechanistically and clinically. Trials have shown that treating PD in people with RA may improve RA disease activity. Patients with musculoskeletal symptoms without arthritis, who test positive for cyclic-citrullinated protein antibodies, are at risk of RA (CCP+ at-risk), with seropositivity preceding arthritis onset by months or years.
View Article and Find Full Text PDF